🚨 #APHINITY Trial • #ESMOBreast25🚨 Pertuzumab (Perjeta) + trastuzumab (Herceptin) + chemo significantly improves long-term survival for people with HER2-positive early-stage breast cancer, especially those with lymph node involvement or hormone receptor–positive tumors. Read more 🔗 bit.ly/ESMO2025